PharmOncology

← PharmOncology26. Aug. · 11 Min.

ESR1 mutations, elacestrant, imlunestrant, and vepdegestrant

ESR1 mutations, elacestrant, imlunestrant, and vepdegestrant26. Aug.11 Min.

<p>How ESR1 mutations develop in breast cancer, targeting them, and some differences between elacestrant, imlunestrant, and vepdegestrant</p>